High-fat diet increases vulnerability to atrial arrhythmia by conduction disturbance via miR-27b

Journal of Molecular and Cellular Cardiology

Volumn 90, Issue , 2016, Pages 38-46

  Takahashi, Kentaro ^a   Sasano, Tetsuo ^b   Sugiyama, Koji ^a   Kurokawa, Junko ^b   Tamura, Noriko ^a   Soejima, Yurie ^b   Sawabe, Motoji ^b   Isobe, Mitsuaki ^a   Furukawa, Tetsushi ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Electrical remodeling; Gap junction; Lipids; MicroRNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CONNEXIN 40; CYTOKINE; MICRORNA; MIR 27B; PALMITIC ACID; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; GAP JUNCTION PROTEIN; MIRN27 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CONDUCTION VELOCITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HEART ATRIUM ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; INFLAMMATION; LIPID DIET; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; P WAVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SUPRAVENTRICULAR TACHYCARDIA; UPREGULATION; ADVERSE EFFECTS; ANIMAL; ARRHYTHMIA, SINUS; BRUGADA SYNDROME; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL LINE; CYTOLOGY; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART ATRIUM; HEK293 CELL LINE; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOLOGY; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; ANIMALS; ARRHYTHMIA, SINUS; BRUGADA SYNDROME; CELL LINE; CONNEXINS; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; HEART ATRIA; HEK293 CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN CULTURE TECHNIQUES; PALMITIC ACID; SIGNAL TRANSDUCTION;

EID: 84949293310     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.11.034     Document Type: Article

References (46)

1. Nattel S. New ideas about atrial fibrillation 50years on. Nature 2002, 415:219-226.
2. Wang T.J., Parise H., Levy D., D'Agostino R.B., Wolf P.A., Vasan R.S., et al. Obesity and the risk of new-onset atrial fibrillation. J. Am. Med. Assoc. 2004, 292:2471-2477.
3. Watanabe H., Tanabe N., Watanabe T., Darbar D., Roden D.M., Sasaki S., et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008, 117:1255-1260.
4. Mattioli A., Miloro C., Pennella S., Pedrazzi P., Farinetti A. Adherence to Mediterranean diet and intake of antioxidants influence spontaneous conversion of atrial fibrillation. Nutr. Metab. Cardiovasc. Dis. 2013, 23:115-121.
5. Nattel S., Burstein B., Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ. Arrhythm. Electrophysiol. 2008, 1:62-73.
6. Kume O., Takahashi N., Wakisaka O., Nagano-Torigoe Y., Teshima Y., Nakagawa M., et al. Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats. Heart Rhythm. 2011, 8:278-285.
7. Friedrichs K., Klinke A., Baldus S. Inflammatory pathways underlying atrial fibrillation. Trends Mol. Med. 2011, 17:556-563.
8. Oishi S., Sasano T., Tateishi Y., Tamura N., Isobe M., Furukawa T. Stretch of atrial myocytes stimulates recruitment of macrophages via ATP released through gap-junction channels. J. Pharmacol. Sci. 2012, 120:296-304.
9. Burstein B., Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J. Am. Coll. Cardiol. 2008, 51:802-809.
10. Liao C.H., Akazawa H., Tamagawa M., Ito K., Yasuda N., Kudo Y., et al. Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J. Clin. Invest. 2010, 120:242-253.
11. Chen Y.H., Xu S.J., Bendahhou S., Wang X.L., Wang Y., Xu W.Y., et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003, 299:251-254.
12. Darbar D., Kannankeril P.J., Donahue B.S., Kucera G., Stubblefield T., Haines J.L., et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 2008, 117:1927-1935.
13. Sinner M.F., Pfeufer A., Akyol M., Beckmann B.M., Hinterseer M., Wacker A., et al. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur. Heart J. 2008, 29:907-914.
14. Thibodeau I.L., Xu J., Li Q., Liu G., Lam K., Veinot J.P., et al. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue. Circulation 2010, 122:236-244.
15. Gollob M.H., Jones D.L., Krahn A.D., Danis L., Gong X.Q., Shao Q., et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N. Engl. J. Med. 2006, 354:2677-2688.
16. Boettger T., Braun T. A new level of complexity: the role of microRNAs in cardiovascular development. Circ. Res. 2012, 110:1000-1013.
17. Quiat D., Olson E.N. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J. Clin. Invest. 2013, 123:11-18.
18. Dawson K., Wakili R., Ordog B., Clauss S., Chen Y., Iwasaki Y., et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 2013.
19. Luo X., Pan Z., Shan H., Xiao J., Sun X., Wang N., et al. MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J. Clin. Invest. 2013.
20. Vickers K.C., Shoucri B.M., Levin M.G., Wu H., Pearson D.S., Osei-Hwedieh D., et al. MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology 2013, 57:533-542.
21. Pandey A.K., Agarwal P., Kaur K., Datta M. MicroRNAs in diabetes: tiny players in big disease. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 2009, 23:221-232.
22. Lee K.T., Hsieh C.C., Tsai W.C., Tang P.W., Liu I.H., Chai C.Y., et al. Characteristics of atrial substrates for atrial tachyarrhythmias induced in aged and hypercholesterolemic rabbits. Pacing and Clinical Electrophysiology: PACE 2012, 35:544-552.
23. Abed H.S., Samuel C.S., Lau D.H., Kelly D.J., Royce S.G., Alasady M., et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013, 10:90-100.
24. Claycomb W.C., Lanson N.A., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:2979-2984.
25. Wakimoto H., Maguire C.T., Kovoor P., Hammer P.E., Gehrmann J., Triedman J.K., et al. Induction of atrial tachycardia and fibrillation in the mouse heart. Cardiovasc. Res. 2001, 50:463-473.
26. Sasano T., McDonald A.D., Kikuchi K., Donahue J.K. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat. Med. 2006, 12:1256-1258.
27. Hsu S.D., Tseng Y.T., Shrestha S., Lin Y.L., Khaleel A., Chou C.H., et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2014, 42:D78-D85.
28. Chalkiadaki A., Guarente L. High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab. 2012, 16:180-188.
29. Yue L., Feng J., Gaspo R., Li G.R., Wang Z., Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ. Res. 1997, 81:512-525.
30. Hagendorff A., Schumacher B., Kirchhoff S., Luderitz B., Willecke K. Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 1999, 99:1508-1515.
31. Sato P.Y., Musa H., Coombs W., Guerrero-Serna G., Patino G.A., Taffet S.M., et al. Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ. Res. 2009, 105:523-526.
32. Wende A.R., Abel E.D. Lipotoxicity in the heart. Biochim. Biophys. Acta 1801, 2010:311-319.
33. Kuwabara Y., Horie T., Baba O., Watanabe S., Nishiga M., Usami S., et al. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Circ. Res. 2015, 116:279-288.
34. Wang Z., Li L., Zhao H., Peng S., Zuo Z. Chronic high fat diet induces cardiac hypertrophy and fibrosis in mice. Metabolism: Clinical and Experimental 2015, 64:917-925.
35. Vozzi C., Dupont E., Coppen S.R., Yeh H.I., Severs N.J. Chamber-related differences in connexin expression in the human heart. J. Mol. Cell. Cardiol. 1999, 31:991-1003.
36. Rignault S., Haefliger J.A., Waeber B., Liaudet L., Feihl F. Acute inflammation decreases the expression of connexin 40 in mouse lung. Shock 2007, 28:78-85.
37. Yeh H.I., Lu C.S., Wu Y.J., Chen C.C., Hong R.C., Ko Y.S., et al. Reduced expression of endothelial connexin37 and connexin40 in hyperlipidemic mice: recovery of connexin37 after 7-day simvastatin treatment. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1391-1397.
38. Makino A., Platoshyn O., Suarez J., Yuan J.X., Dillmann W.H. Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice. Am. J. Physiol. Cell Physiol. 2008, 295:C221-C230.
39. Lin Q., Gao Z., Alarcon R.M., Ye J., Yun Z. A role of miR-27 in the regulation of adipogenesis. FEBS J. 2009, 276:2348-2358.
40. Wang J., Song Y., Zhang Y., Xiao H., Sun Q., Hou N., et al. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res. 2012, 22:516-527.
41. Xu D., Murakoshi N., Igarashi M., Hirayama A., Ito Y., Seo Y., et al. PPAR-gamma activator pioglitazone prevents age-related atrial fibrillation susceptibility by improving antioxidant capacity and reducing apoptosis in a rat model. J. Cardiovasc. Electrophysiol. 2012, 23:209-217.
42. Conway D.S., Buggins P., Hughes E., Lip G.Y. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am. Heart J. 2004, 148:462-466.
43. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E745-E51.
44. Rommel J., Simpson R., Mounsey J.P., Chung E., Schwartz J., Pursell I., et al. Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation. Am. J. Cardiol. 2013, 111:208-212.
45. Qian J., Zhang Z., Liang J., Ge Q., Duan X., Ma F., et al. The full-length transcripts and promoter analysis of intergenic microRNAs in Drosophila melanogaster. Genomics 2011, 97:294-303.
46. Jin L., Wessely O., Marcusson E.G., Ivan C., Calin G.A., Alahari S.K. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-alpha in breast cancer. Cancer Res. 2013, 73:2884-2896.